<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p188" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_188{left:35px;bottom:24px;letter-spacing:-0.34px;word-spacing:0.13px;}
#t2_188{left:306px;bottom:30px;}
#t3_188{left:313px;bottom:24px;letter-spacing:0.16px;}
#t4_188{left:346px;bottom:30px;}
#t5_188{left:351px;bottom:24px;letter-spacing:-0.16px;word-spacing:-0.22px;}
#t6_188{left:517px;bottom:30px;}
#t7_188{left:524px;bottom:24px;letter-spacing:-0.28px;word-spacing:-0.09px;}
#t8_188{left:288px;bottom:860px;letter-spacing:0.11px;word-spacing:-0.55px;}
#t9_188{left:288px;bottom:829px;letter-spacing:0.27px;word-spacing:-0.69px;}
#ta_188{left:1115px;bottom:27px;letter-spacing:0.23px;}
#tb_188{left:35px;bottom:777px;letter-spacing:0.07px;word-spacing:0.12px;}
#tc_188{left:359px;bottom:785px;letter-spacing:-0.01px;}
#td_188{left:383px;bottom:777px;letter-spacing:0.11px;word-spacing:0.07px;}
#te_188{left:35px;bottom:754px;letter-spacing:0.07px;word-spacing:0.12px;}
#tf_188{left:35px;bottom:731px;letter-spacing:0.01px;word-spacing:0.18px;}
#tg_188{left:35px;bottom:707px;letter-spacing:0.11px;word-spacing:0.08px;}
#th_188{left:35px;bottom:684px;letter-spacing:0.06px;word-spacing:-0.49px;}
#ti_188{left:35px;bottom:661px;letter-spacing:0.18px;}
#tj_188{left:35px;bottom:638px;letter-spacing:0.23px;}
#tk_188{left:35px;bottom:599px;letter-spacing:0.11px;word-spacing:0.08px;}
#tl_188{left:35px;bottom:575px;letter-spacing:0.06px;word-spacing:0.13px;}
#tm_188{left:310px;bottom:583px;letter-spacing:-0.01px;}
#tn_188{left:334px;bottom:575px;letter-spacing:0.15px;word-spacing:0.04px;}
#to_188{left:35px;bottom:552px;letter-spacing:0.1px;word-spacing:-0.33px;}
#tp_188{left:572px;bottom:560px;letter-spacing:-0.01px;}
#tq_188{left:35px;bottom:529px;letter-spacing:-0.01px;word-spacing:-0.21px;}
#tr_188{left:35px;bottom:506px;letter-spacing:0.27px;}
#ts_188{left:75px;bottom:506px;letter-spacing:0.26px;word-spacing:-0.06px;}
#tt_188{left:231px;bottom:506px;letter-spacing:0.13px;word-spacing:0.06px;}
#tu_188{left:35px;bottom:482px;letter-spacing:0.02px;word-spacing:0.17px;}
#tv_188{left:35px;bottom:459px;letter-spacing:0.01px;word-spacing:0.17px;}
#tw_188{left:35px;bottom:436px;letter-spacing:0.14px;word-spacing:0.05px;}
#tx_188{left:35px;bottom:413px;letter-spacing:0.14px;word-spacing:0.04px;}
#ty_188{left:35px;bottom:390px;letter-spacing:-0.21px;word-spacing:1px;}
#tz_188{left:226px;bottom:390px;letter-spacing:0.06px;}
#t10_188{left:347px;bottom:390px;letter-spacing:0.45px;}
#t11_188{left:358px;bottom:397px;letter-spacing:0.1px;}
#t12_188{left:35px;bottom:349px;letter-spacing:0.23px;word-spacing:-0.03px;}
#t13_188{left:35px;bottom:320px;letter-spacing:-0.02px;word-spacing:0.21px;}
#t14_188{left:35px;bottom:297px;letter-spacing:0.08px;word-spacing:-0.38px;}
#t15_188{left:35px;bottom:273px;letter-spacing:0.11px;word-spacing:-0.93px;}
#t16_188{left:35px;bottom:250px;letter-spacing:0.07px;word-spacing:0.12px;}
#t17_188{left:35px;bottom:227px;letter-spacing:0.13px;word-spacing:0.06px;}
#t18_188{left:35px;bottom:204px;letter-spacing:0.15px;word-spacing:0.03px;}
#t19_188{left:35px;bottom:181px;letter-spacing:0.06px;word-spacing:0.25px;}
#t1a_188{left:35px;bottom:159px;letter-spacing:0.06px;word-spacing:0.13px;}
#t1b_188{left:35px;bottom:135px;letter-spacing:0.11px;word-spacing:0.07px;}
#t1c_188{left:35px;bottom:112px;letter-spacing:0.05px;word-spacing:0.01px;}
#t1d_188{left:35px;bottom:89px;letter-spacing:0.03px;word-spacing:-0.96px;}
#t1e_188{left:35px;bottom:66px;letter-spacing:0.23px;}
#t1f_188{left:116px;bottom:73px;letter-spacing:-0.01px;}
#t1g_188{left:139px;bottom:66px;letter-spacing:0.05px;word-spacing:0.14px;}
#t1h_188{left:618px;bottom:777px;letter-spacing:0.09px;word-spacing:0.09px;}
#t1i_188{left:618px;bottom:754px;letter-spacing:0.14px;word-spacing:-0.73px;}
#t1j_188{left:618px;bottom:731px;letter-spacing:0.06px;word-spacing:-0.18px;}
#t1k_188{left:618px;bottom:707px;letter-spacing:0.14px;word-spacing:0.05px;}
#t1l_188{left:859px;bottom:715px;letter-spacing:-0.01px;}
#t1m_188{left:618px;bottom:667px;letter-spacing:0.12px;word-spacing:0.07px;}
#t1n_188{left:618px;bottom:645px;letter-spacing:0.15px;word-spacing:0.04px;}
#t1o_188{left:618px;bottom:622px;letter-spacing:0.11px;word-spacing:0.08px;}
#t1p_188{left:618px;bottom:599px;letter-spacing:0.04px;word-spacing:0.15px;}
#t1q_188{left:618px;bottom:575px;letter-spacing:0.05px;word-spacing:-0.04px;}
#t1r_188{left:618px;bottom:552px;letter-spacing:0.1px;word-spacing:0.08px;}
#t1s_188{left:618px;bottom:529px;letter-spacing:0.21px;word-spacing:-0.02px;}
#t1t_188{left:799px;bottom:529px;letter-spacing:0.13px;word-spacing:0.06px;}
#t1u_188{left:618px;bottom:506px;letter-spacing:0.16px;word-spacing:0.03px;}
#t1v_188{left:618px;bottom:482px;letter-spacing:0.15px;word-spacing:0.04px;}
#t1w_188{left:618px;bottom:459px;letter-spacing:0.12px;word-spacing:0.06px;}
#t1x_188{left:618px;bottom:436px;letter-spacing:0.07px;word-spacing:-0.88px;}
#t1y_188{left:618px;bottom:413px;letter-spacing:0.08px;word-spacing:0.11px;}
#t1z_188{left:618px;bottom:390px;letter-spacing:0.11px;word-spacing:0.08px;}
#t20_188{left:618px;bottom:366px;letter-spacing:0.18px;word-spacing:0.01px;}
#t21_188{left:618px;bottom:326px;letter-spacing:0.14px;word-spacing:0.05px;}
#t22_188{left:618px;bottom:303px;letter-spacing:0.06px;word-spacing:0.13px;}
#t23_188{left:618px;bottom:280px;letter-spacing:0.12px;word-spacing:0.07px;}
#t24_188{left:618px;bottom:256px;letter-spacing:0.12px;word-spacing:-1.17px;}
#t25_188{left:896px;bottom:256px;letter-spacing:0.17px;word-spacing:-0.6px;}
#t26_188{left:618px;bottom:233px;letter-spacing:0.26px;word-spacing:-0.06px;}
#t27_188{left:766px;bottom:233px;letter-spacing:0.11px;word-spacing:0.08px;}
#t28_188{left:618px;bottom:210px;letter-spacing:0.16px;word-spacing:0.03px;}
#t29_188{left:618px;bottom:187px;letter-spacing:0.19px;word-spacing:-0.01px;}
#t2a_188{left:618px;bottom:163px;letter-spacing:0.11px;word-spacing:0.08px;}
#t2b_188{left:618px;bottom:124px;letter-spacing:0.13px;word-spacing:0.06px;}
#t2c_188{left:618px;bottom:101px;letter-spacing:0.07px;word-spacing:-1px;}
#t2d_188{left:618px;bottom:78px;letter-spacing:0.06px;word-spacing:0.13px;}
#t2e_188{left:710px;bottom:85px;letter-spacing:0.1px;}
#t2f_188{left:755px;bottom:78px;letter-spacing:0.16px;word-spacing:0.02px;}
#t2g_188{left:618px;bottom:55px;letter-spacing:0.07px;word-spacing:-0.87px;}
#t2h_188{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_188{font-size:10px;font-family:ArialMT_5tg;color:#000;}
.s1_188{font-size:6px;font-family:ArialMT_5tg;color:#000;}
.s2_188{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_188{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_188{font-size:17px;font-family:ArialMT_5tg;color:#000;}
.s5_188{font-size:11px;font-family:ArialMT_5tg;color:#000;}
.s6_188{font-size:17px;font-family:Arial-ItalicMT_kb;color:#000;}
.s7_188{font-size:17px;font-family:ArialMT_5tg;color:#005B99;}
.s8_188{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts188" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-ItalicMT_kb;
	src: url("fonts/Arial-ItalicMT_kb.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg188Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg188" style="-webkit-user-select: none;"><object width="1210" height="935" data="188/188.svg" type="image/svg+xml" id="pdf188" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_188" class="t s0_188">Version 4.2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_188" class="t s1_188">© </span>
<span id="t3_188" class="t s0_188">(NCCN </span>
<span id="t4_188" class="t s1_188">© </span>
<span id="t5_188" class="t s0_188">), All rights reserved. NCCN Guidelines </span>
<span id="t6_188" class="t s1_188">® </span>
<span id="t7_188" class="t s0_188">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_188" class="t s2_188">NCCN Guidelines Version 4.2024 </span>
<span id="t9_188" class="t s2_188">Head and Neck Cancers </span>
<span id="ta_188" class="t s3_188">MS-47 </span>
<span id="tb_188" class="t s4_188">SNUC, and SNEC continue to be debated, </span>
<span id="tc_188" class="t s5_188">587 </span>
<span id="td_188" class="t s4_188">and correct pathologic </span>
<span id="te_188" class="t s4_188">diagnosis is paramount for treatment decision-making. In the case of </span>
<span id="tf_188" class="t s4_188">midline NUT carcinoma, a specific diagnosis is made based upon </span>
<span id="tg_188" class="t s4_188">immunohistochemistry or pathognomonic NUT gene rearrangement. For </span>
<span id="th_188" class="t s4_188">patients diagnosed with these diseases, referral to a major medical center </span>
<span id="ti_188" class="t s4_188">with expertise in confirming diagnosis of these tumors should be </span>
<span id="tj_188" class="t s4_188">considered. </span>
<span id="tk_188" class="t s4_188">Locoregional control and risk of distant metastasis are dependent on T </span>
<span id="tl_188" class="t s4_188">stage, N stage, and tumor histology. </span>
<span id="tm_188" class="t s5_188">588 </span>
<span id="tn_188" class="t s4_188">However, T stage (see Table 6) </span>
<span id="to_188" class="t s4_188">remains the most reliable predictor of survival and locoregional control. </span>
<span id="tp_188" class="t s5_188">391 </span>
<span id="tq_188" class="t s4_188">MM also occurs in the paranasal sinus region, nasal cavity, and oral cavity </span>
<span id="tr_188" class="t s4_188">(see </span><span id="ts_188" class="t s6_188">Mucosal Melanoma </span><span id="tt_188" class="t s4_188">in the NCCN Guidelines for Head and Neck </span>
<span id="tu_188" class="t s4_188">Cancers). Sarcoma and lymphoma should also be considered in the </span>
<span id="tv_188" class="t s4_188">differential diagnosis when evaluating a patient with a paranasal sinus </span>
<span id="tw_188" class="t s4_188">tumor (see the NCCN Guidelines for Soft Tissue Sarcoma, the NCCN </span>
<span id="tx_188" class="t s4_188">Guidelines for B-Cell Lymphomas, and the NCCN Guidelines for T-Cell </span>
<span id="ty_188" class="t s4_188">Lymphomas, available at </span><span id="tz_188" class="t s7_188">www.NCCN.org</span><span id="t10_188" class="t s4_188">). </span>
<span id="t11_188" class="t s5_188">589,590 </span>
<span id="t12_188" class="t s3_188">Ethmoid Sinus Tumors </span>
<span id="t13_188" class="t s4_188">Patients with early-stage ethmoid sinus cancer are typically asymptomatic </span>
<span id="t14_188" class="t s4_188">or have minor symptoms of nasal stuffiness, epistaxis, or anosmia. These </span>
<span id="t15_188" class="t s4_188">neoplasms are often found after a routine nasal polypectomy or during the </span>
<span id="t16_188" class="t s4_188">course of a nasal endoscopic examination. For a patient with gross </span>
<span id="t17_188" class="t s4_188">residual disease left behind after an initial endoscopic procedure, an </span>
<span id="t18_188" class="t s4_188">oncologically complete resection of the residual tumor is required. This </span>
<span id="t19_188" class="t s4_188">may be done endoscopically or with an open approach. In some </span>
<span id="t1a_188" class="t s4_188">instances, this procedure may entail an anterior craniofacial resection to </span>
<span id="t1b_188" class="t s4_188">remove the cribriform plate and intracranial component of the tumor to </span>
<span id="t1c_188" class="t s4_188">ensure clear surgical margins. Nodal involvement is rare in ethmoid sinus </span>
<span id="t1d_188" class="t s4_188">tumors, and, when present, lymph node metastasis is associated with poor </span>
<span id="t1e_188" class="t s4_188">prognosis. </span>
<span id="t1f_188" class="t s5_188">591 </span>
<span id="t1g_188" class="t s4_188">Patients with ethmoid sinus cancer who have N+ neck </span>
<span id="t1h_188" class="t s4_188">disease should undergo neck dissection with adjuvant therapy as </span>
<span id="t1i_188" class="t s4_188">appropriate based on the presence of adverse histopathological features. </span>
<span id="t1j_188" class="t s4_188">Patients with high-grade tumors have worse survival outcomes compared </span>
<span id="t1k_188" class="t s4_188">to those with low-grade tumors. </span>
<span id="t1l_188" class="t s5_188">592 </span>
<span id="t1m_188" class="t s4_188">Often patients with ethmoid sinus cancer present after having had an </span>
<span id="t1n_188" class="t s4_188">incomplete endoscopic resection. The patient who is diagnosed after </span>
<span id="t1o_188" class="t s4_188">incomplete resection (eg, polypectomy with histologically positive </span>
<span id="t1p_188" class="t s4_188">margin)—and has no documented residual disease on physical </span>
<span id="t1q_188" class="t s4_188">examination, imaging, and/or endoscopy—should be treated with surgical </span>
<span id="t1r_188" class="t s4_188">resection to obtain oncologically appropriate margins if feasible (see </span>
<span id="t1s_188" class="t s6_188">Ethmoid Sinus Tumors </span><span id="t1t_188" class="t s4_188">in the NCCN Guidelines for Head and Neck </span>
<span id="t1u_188" class="t s4_188">Cancers). If no adverse pathologic features are found, complete surgical </span>
<span id="t1v_188" class="t s4_188">resection may obviate the need for postoperative RT in T1 patients only </span>
<span id="t1w_188" class="t s4_188">(category 2B). In patients with high-risk pathologic features, such as </span>
<span id="t1x_188" class="t s4_188">positive or close margins adjacent to vital structures, high-grade lesions or </span>
<span id="t1y_188" class="t s4_188">other unfavorable histology, and/or intracranial and/or intraorbital </span>
<span id="t1z_188" class="t s4_188">extension, postoperative RT is recommended, and possibly systemic </span>
<span id="t20_188" class="t s4_188">therapy/RT could be considered (category 2B). </span>
<span id="t21_188" class="t s4_188">RT or concurrent systemic therapy/RT may be considered as definitive </span>
<span id="t22_188" class="t s4_188">treatment in patients for whom an oncologically satisfactory surgical </span>
<span id="t23_188" class="t s4_188">resection is not possible. Radiation therapy fractionation for patients with </span>
<span id="t24_188" class="t s4_188">ethmoid sinus tumors is described in </span><span id="t25_188" class="t s6_188">Ethmoid Sinus Tumors: Principles of </span>
<span id="t26_188" class="t s6_188">Radiation Therapy </span><span id="t27_188" class="t s4_188">in the NCCN Guidelines for Head and Neck Cancers. </span>
<span id="t28_188" class="t s4_188">IMRT is preferred due to the proximity of this anatomic area to the optic </span>
<span id="t29_188" class="t s4_188">structures; proton therapy should be considered if the normal tissue </span>
<span id="t2a_188" class="t s4_188">constraints cannot be met by IMRT. </span>
<span id="t2b_188" class="t s4_188">Systemic therapy/RT may be considered to preserve the orbital contents </span>
<span id="t2c_188" class="t s4_188">and avoid incomplete surgery in patients with T4 disease, based on limited </span>
<span id="t2d_188" class="t s4_188">case series. </span>
<span id="t2e_188" class="t s5_188">593,594 </span>
<span id="t2f_188" class="t s4_188">In these patients, induction and concurrent </span>
<span id="t2g_188" class="t s4_188">chemotherapy may be given in combination with RT. A retrospective study </span>
<span id="t2h_188" class="t s8_188">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
